Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Iovance Biotherapeutics (IOVA) Shares Issued: 2010-2025

Historic Shares Issued for Iovance Biotherapeutics (IOVA) over the last 7 years, with Sep 2025 value amounting to $88.5 million.

  • Iovance Biotherapeutics' Shares Issued rose 86.29% to $88.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $298.0 million, marking a year-over-year decrease of 24.98%. This contributed to the annual value of $397.3 million for FY2024, which is 14.24% down from last year.
  • Per Iovance Biotherapeutics' latest filing, its Shares Issued stood at $88.5 million for Q3 2025, which was up 577.54% from $13.1 million recorded in Q2 2025.
  • Iovance Biotherapeutics' 5-year Shares Issued high stood at $260.1 million for Q1 2023, and its period low was $1,000 during Q4 2023.
  • Its 3-year average for Shares Issued is $123.5 million, with a median of $148.9 million in 2025.
  • Data for Iovance Biotherapeutics' Shares Issued shows a peak YoY increase of 86.29% (in 2025) and a maximum YoY decrease of 91.40% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Iovance Biotherapeutics' Shares Issued stood at $1,000 in 2023, then plummeted by 76.61% to $47.5 million in 2024, then surged by 86.29% to $88.5 million in 2025.
  • Its Shares Issued was $88.5 million in Q3 2025, compared to $13.1 million in Q2 2025 and $148.9 million in Q1 2025.